Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abingdon Health PLC (GB:ABDX)
LSE:ABDX
Holding GB:ABDX?
Track your performance easily
ABDX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range6.50p - 14.00p
Previous Close9.3p
Volume96.86K
Average Volume (3M)137.67K
Market Cap
£18.01M
Enterprise Value15.79M
Total Cash (Recent Filing)£3.24M
Total Debt (Recent Filing)£1.02M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Nov 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding243,112,894
10 Day Avg. Volume68,460
30 Day Avg. Volume137,673
Standard Deviation0.19
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)955.00
Price to Sales (P/S)4.34
Price to Cash Flow (P/CF)-9.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Abingdon Health PLC News
PremiumCompany Announcements
Abingdon Health Secures £5.665M from Share Issuance
PremiumCompany Announcements
Abingdon Health Share Issuance Dilutes Stakes
PremiumCompany Announcements
Northern Powerhouse Fund Acquires Major Stake in Abingdon Health
PremiumCompany Announcements
Canaccord Genuity Acquires Significant Stake in Abingdon Health
PremiumCompany Announcements
Abingdon Health Notifies of Major Shareholding Change
PremiumCompany Announcements
Abingdon Health PLC Reports Major Share Ownership Change
PremiumCompany Announcements
Abingdon Health Launches Exclusive Retail Share OfferPremiumCompany Announcements
Abingdon Health Completes Strategic AcquisitionOptions Prices
Currently, No data available
---
Ownership Overview
10.88% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
89.12% Public Companies and
Individual Investors
ABDX FAQ
What was Abingdon Health PLC’s price range in the past 12 months?
Abingdon Health PLC lowest share price was 6.50p and its highest was 14.00p in the past 12 months.
What is Abingdon Health PLC’s market cap?
Currently, no data Available
When is Abingdon Health PLC’s upcoming earnings report date?
Abingdon Health PLC’s upcoming earnings report date is Nov 14, 2024 which is in 55 days.
How were Abingdon Health PLC’s earnings last quarter?
Abingdon Health PLC released its earnings results on Mar 14, 2024. The company reported -0.004p earnings per share for the quarter, missing the consensus estimate of N/A by -0.004p.
Is Abingdon Health PLC overvalued?
According to Wall Street analysts Abingdon Health PLC’s price is currently Overvalued.
Does Abingdon Health PLC pay dividends?
Abingdon Health PLC does not currently pay dividends.
What is Abingdon Health PLC’s EPS estimate?
Abingdon Health PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abingdon Health PLC have?
Abingdon Health PLC has 193,630,810 shares outstanding.
What happened to Abingdon Health PLC’s price movement after its last earnings report?
Abingdon Health PLC reported an EPS of -0.004p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 28.296%.
Which hedge fund is a major shareholder of Abingdon Health PLC?
Currently, no hedge funds are holding shares in GB:ABDX
---
Abingdon Health PLC Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.45%
12-Months-Change
Fundamentals
Return on Equity
-76.65%
Trailing 12-Months
Asset Growth
-31.92%
Trailing 12-Months
Company Description
Abingdon Health PLC
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in the healthcare sector and other industries. The company's product, AbC-19, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. Also, the company produces lateral flow tests covering areas such as self-test HIV, equine infection, human fertility, blood cancer and other infectious diseases.
---
Technical Analysis
---